Stay updated on TRuE AD1 Clinical Trial
Sign up to get notified when there's something new on the TRuE AD1 Clinical Trial page.

Latest updates to the TRuE AD1 Clinical Trial page
- Check3 days agoChange DetectedThe page’s displayed revision/version identifier was updated from v3.5.2 to v3.5.3.SummaryDifference0.0%

- Check10 days agoChange DetectedA new Publications entry related to Ruxolitinib cream efficacy and safety in atopic dermatitis was added, while an earlier online-ahead-of-print citation for the same topic was removed.SummaryDifference0.1%

- Check17 days agoNo Change Detected
- Check39 days agoChange DetectedRevision: v3.5.0 has been added. Revision: v3.4.3 has been removed.SummaryDifference0.0%

- Check53 days agoChange DetectedRevision updated from v3.4.2 to v3.4.3 on the page.SummaryDifference0.0%

- Check67 days agoChange DetectedAdded a new publication entry to the Publications section: Blauvelt A, et al. Ruxolitinib Cream As-Needed Monotherapy Demonstrates Sustained Disease and Symptom Control in Patients with Mild to Moderate Atopic Dermatitis: Pooled Analysis from Two Phase 3 Studies. Dermatol Ther (Heidelb). 2026 Feb 12. doi: 10.1007/s13555-025-01639-0. Online ahead of print.SummaryDifference0.0%

- Check74 days agoChange DetectedRevision: v3.4.2 has been added, replacing the previous v3.4.1. This is a minor update and does not affect study content or access to information. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

Stay in the know with updates to TRuE AD1 Clinical Trial
Enter your email address, and we'll notify you when there's something new on the TRuE AD1 Clinical Trial page.